PROCESSA PHARMACEUTICALS INC (PCSA) Stock Analyst Ratings
USA - NASDAQ:PCSA - US74275C3043 - Common Stock
0.3058 USD
-0.01 (-3.2%)
0.3088 USD
+0 (+0.98%)
ChartMill assigns a Buy % Consensus number of 80% to PCSA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.02. This target is 233.55% above the current price.
PCSA was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PCSA.
In the previous month the buy percentage consensus was at a similar level.
PCSA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-25 | HC Wainwright & Co. | Initiate | Buy |
| 2024-03-06 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-11-17 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-04-04 | Benchmark | Maintains | Speculative Buy |
| 2023-04-03 | Oppenheimer | Maintains | Outperform |
| 2023-01-12 | Maxim Group | Maintains | Buy |
| 2022-04-19 | Maxim Group | Initiate | Buy |
| 2021-08-03 | Oppenheimer | Initiate | Outperform |
| 2021-08-02 | Oppenheimer | Initiate | Outperform |
PROCESSA PHARMACEUTICALS INC / PCSA FAQ
What is the price target for PCSA stock?
8 analysts have analysed PCSA and the average price target is 1.02 USD. This implies a price increase of 233.55% is expected in the next year compared to the current price of 0.3058.
Can you provide the consensus rating for PROCESSA PHARMACEUTICALS INC stock?
The consensus rating for PROCESSA PHARMACEUTICALS INC (PCSA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for PROCESSA PHARMACEUTICALS INC stock?
The number of analysts covering PROCESSA PHARMACEUTICALS INC (PCSA) is 8.